Format

Send to

Choose Destination
Anticancer Res. 2012 Apr;32(4):1537-42.

Impact of epidural analgesia on survival in patients undergoing complete cytoreductive surgery for ovarian cancer.

Author information

1
Department of Surgery, Institut Gustave Roussy, Villejuif, France.

Abstract

BACKGROUND:

Potential benefits of regional analgesia in reduction of cancer recurrence have been reported for breast and prostate cancer. The aim of this study was to evaluate the influence of regional analgesia on recurrence-free survival and overall survival in patients with advanced-stage ovarian cancer (ASOC) following complete cytoreduction.

PATIENTS AND METHODS:

This is a retrospective study of 104 patients who had undergone complete cytoreduction for ASOC between 01/2007 and 12/2009: 51 with patient controlled epidural analgesia (PCEA) and 53 without PCEA.

RESULTS:

No significant difference was found between the two groups in terms of overall survival, while there was a trend in favour of PCEA for disease free survival.

CONCLUSION:

In our study, regional analgesia had no clear impact on cancer recurrence. More studies on this subject are warranted in order to determine the possible impact of regional analgesia on ASOC.

PMID:
22493398
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center